QHP’s pharma single-asset delivers 10x for selling LPs

This is at least the second time the mid-market healthcare-focused firm has run a CV to extend its hold of a top-performing asset.

SECONDARIES INVESTOR

Register to unlock this content

• Daily global secondaries market news and intelligence
• Curated insights to keep you ahead of GP-led and LP-led secondaries
• Faster, data-driven decision making powered by our AI interface, 'Ask PEI'
• Access to proprietary research and reports
• Selected fund performance and investor activity data

Register nowFind out more

DealsNorth AmericaSingle AssetsFeaturedGP-Leds